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Automated segmentation 
of endometrial cancer on MR 
images using deep learning
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Antonella Z. Munthe‑Kaas2,4, Kristine E. Fasmer2,3, Camilla Krakstad5,6, Arvid Lundervold2,7, 
Alexander S. Lundervold2,8, Øyvind Salvesen9, Bradley J. Erickson10 & Ingfrid Haldorsen2,3
Preoperative MR imaging in endometrial cancer patients provides valuable information on local tumor 
extent, which routinely guides choice of surgical procedure and adjuvant therapy. Furthermore, 
whole‑volume tumor analyses of MR images may provide radiomic tumor signatures potentially 
relevant for better individualization and optimization of treatment. We apply a convolutional neural 
network for automatic tumor segmentation in endometrial cancer patients, enabling automated 
extraction of tumor texture parameters and tumor volume. The network was trained, validated 
and tested on a cohort of 139 endometrial cancer patients based on preoperative pelvic imaging. 
The algorithm was able to retrieve tumor volumes comparable to human expert level (likelihood‑
ratio test, p = 0.06 ). The network was also able to provide a set of segmentation masks with human 
agreement not different from inter‑rater agreement of human experts (Wilcoxon signed rank test, 
p = 0.08 , p = 0.60 , and p = 0.05 ). An automatic tool for tumor segmentation in endometrial cancer 
patients enables automated extraction of tumor volume and whole‑volume tumor texture features. 
This approach represents a promising method for automatic radiomic tumor profiling with potential 
relevance for better prognostication and individualization of therapeutic strategy in endometrial 
cancer.
Endometrial cancer (EC) is the most common gynecologic cancer in industrialized  countries1. EC is surgico-
pathologically staged according to the International Federation of Gynecology and Obstetrics (FIGO) staging 
system. Most patients present with early-stage disease are cured by surgery; however, about 15% develop recur-
rence with limited treatment options and poor  survival2. Routinely reported preoperative imaging findings guide 
surgical approach, and advanced imaging markers may also enable more individualized surgical and adjuvant 
treatment strategies. Valid identification of high-risk patients who are likely to profit from the most invasive 
surgical procedures or from adjuvant therapy, is necessary in order to improve clinical patient care. Thus, novel 
imaging analyses yielding better tools for refined preoperative risk-stratification are urgently needed.
A large family of image texture parameters has been shown to predict high-risk disease and reduced disease 
specific survival in  EC3–6. Also, large primary tumor volume is known to predict advanced stage and aggressive 
 disease7. Manual whole-volume tumor segmentation for accurate calculation of tumor volumes and for genera-
tion of whole-volume texture features is, however, very labor intensive and thus not feasible in daily clinical 
routine. Thus, automatic methods for segmentation of tumors in EC are needed. After the success of ImageNet 
in the Large Scale Visual Recognition  Challenge8, deep learning and convolutional neural networks (CNNs) 
have been increasingly utilized to solve various classification problems in computer vision across domains, 
also within diagnostics and  medicine9,10, e.g. for skin lesion  classification11,12, for identification of intracranial 
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hemorrhages based on CT  scans13, for assessing mortality from chest  radiographs14,15, and for histologic clas-
sification in breast  cancer16.
To date, the majority of deep learning applications have been tailored for segmenting tumors on two-dimen-
sional images, with a large number of applications using variants of the two-dimensional U-Net convolutional 
neural network architecture introduced  previously17. However, high-resolution 3D imaging modalities like MRI 
are commonly used at primary diagnosis for treatment planning in cancer. Recently, platforms and powerful 
frameworks readily available for implementation of medical imaging-based deep-learning applications in 3D have 
been  introduced18–21. This study aimed to utilize 3D CNNs to develop a fully automatic system for the detection 
and delineation of primary EC tumors in 3D in order to facilitate automated extraction of whole-volume tumor 
texture features and tumor volumes.
Results
A total of n = 34 patients comprising the test dataset were used for evaluation of performance. A 3D volume 
rendering of the machine learning (ML) segmentation aligned with the tumor segmentation of rater 1 for one of 
the patients in the validation data set is shown in Fig. 1. The figure depicts large regions of agreement in terms 
of true positives, and also regions of disagreement in terms of false positives and negatives. Examples of 2D 
contours taken from the 3D segmentation masks of machine learning and of the two raters are shown in Fig. 2.
CNN‑based tumor volume estimation. We found no difference in median tumor volume between the 
two raters and the machine learning application (Friedman test, p = 0.28 ). A box plot of tumor volumes is 
shown in Fig. 3.
We found high agreement in tumor volume between the two raters, suggesting that 95% of the observations 
of expert rater 2 will lie within an interval of +/− 10 ml with a bias of − 1.46 ml to expert rater 1 (Bland-Altman 
plot in Fig. 4 , left panel). Strong agreements were also found between the raters and the machine learning 
(Bland-Altman plot in Fig. 4, middle and right panels). These plots suggest that 95% of the observations of the 
machine learning segmentation will stay within an interval of +/− 21.8 ml with a bias of 1.94 ml from rater 1, 
and within +/− 27.5 ml with a bias of 3.4 ml from rater 2.
Excellent consistency in log tumor volume was found between the two raters (ICCR1,R2 = 0.86, 95% CI = (0.77, 
0.94), CI = confidence interval). A high consistency was also found between the machine learning with any of 
the raters (ICCR,ML = 0.76, 95% CI = (0.64, 0.89)). The intraclass correlation coefficients ICCR1,R2 and ICCR,ML 
were not statistically different from each other (likelihood-ratio test, p = 0.06 ), suggesting that the agreement 
in tumor volume is comparable between humans and between humans and machine learning.
Figure 1.  Volume rendering (left panel) of manual and automated ML segmentation of the primary tumor 
from one patient in terms of true positives (orange), false negatives (blue), and false positives (purple). The 
3D segmentation is shown along with the gradient-enhanced 3D volume rendering of the T1-weighted VIBE 
sequence as a background image. Furthermore, three separate paraxial slices from the same data set are depicted 
together with a close-up view of the tumor and outlined segmentations (right panel). A majority of the false 
predictions occur in the tumor periphery, indicated with blue and purple labels. The white, dotted lines are the 
three orthogonal cutting planes used for creating the corresponding slicing plot.
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Figure 2.  Tumor contours of machine learning and the two raters (red solid curves). The contours are 
superimposed on the VIBE image. From left to right: Original VIBE image, contours of ML, rater 1 (R1) 
and rater 2 (R2). Dice similarity coefficients of the respective comparisons are reported as DSCML,R1 = 0.96 , 
DSCML,R2 = 0.89 , DSCR1,R2 = 0.90 respectively.
Figure 3.  Tumor volumes of rater 1, rater 2, and machine learning. We found no difference in median tumor 
volume between the raters and the machine learning application (Friedman test, p = 0.28 ). For each box, the 
central mark shows the median, and the box extends to the 25th and 75th percentiles. The whiskers extend to 
the most extreme data not considered outliers, while outliers are plotted individually.
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Figure 4.  Bland-Altman plots of estimated primary tumor volume [ml] between raters and machine learning. 
Left: Rater 1 tumor volume ( VR1 ) compared to rater 2 tumor volume ( VR2 ). Middle: Rater 1 tumor volume ( VR1 ) 
compared to machine learning tumor volume ( VML ). Right: Rater 2 tumor volume ( VR2 ) compared to machine 
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Evaluation of volumetric segmentation in terms of Dice coefficients, Hausdorff distances, and 
average surface distance. Median DSC for rater 1 with rater 2, rater 1 with ML, and rater 2 with ML were 
0.89, 0.84 and 0.77, respectively (cfr. Fig. 5, left panel). In the plot, five outliers are seen (open dots), representing 
cases with particularly high disagreement between raters. Median tumor volume in the outliers (5.44 ml) was not 
different from median volume in the remaining tumors (7.65 ml) (Wilcoxon rank sum test, p = 0.43 ). Median 
values of HD were 5.15 mm for rater 1 with rater 2, 6.39  mm for rater 1 with ML and 8.69 mm rater 2 with ML 
(Fig. 5, middle panel). Median values of ASD were 0.43 mm for rater 1 with rater 2, 1.08 mm for rater 1 with ML 
and 1.43 mm rater 2 with ML (Fig. 5, right panel).
Median DSC was higher for inter-rater agreement than between the raters and ML (Table 1, panel I, DSC=0.89 
versus DSC=0.84 and DSC=0.77), with a difference in estimate to the human raters of 0.05 and 0.12, respectively. 
A similar result was obtained for HD, where the most optimal HD value was obtained for inter-rater agreement 
(Table 1, panel I, HD = 5.15 mm versus HD = 6.40 mm and HD = 8.69 mm) with absolute differences in estimate 
to the human raters of 1.25 and 3.54 Also for ASD the most optimal value was obtained for inter-rater agree-
ment (Table 1, panel I, ASD = 0.42 mm versus ASD = 1.08 mm and ASD = 1.43 mm) with absolute differences 
in estimate to the human raters of 0.66 mm and 1.00 mm.
Figure 5.  Box plot of DSC, HD, and ASD obtained when comparing segmentations between raters and ML. 
Left plot: Median DSC obtained for inter-rater agreement (left box: R1, R2) is higher than between raters and 
ML (middle and right boxes). Middle plot: The lowest median HD was obtained for inter-rater agreement (left 
box: R1, R2), followed by ML with both of the raters (middle and right boxes). Right plot: The lowest median 
ASD was obtained for inter-rater agreement (left box: R1, R2), followed by ML with both of the raters (middle 
and right boxes). R = rater.
Table 1.  Differences in DSC, HD, and ASD between human raters (R1, R2) and machine learning (ML) in 
the test cohort. Performance is reported for all patients and separately for endometroid ( n = 30 ) and non-
endometroid ( n = 5 ) subtypes. I: Median value of agreements A = rater 1 with rater 2 (inter-rater agreement), 
B = rater 1 with ML, C = rater 2 with ML of DSC, HD, and ASD. II: Absolute difference in median value 
(p-values in brackets) of the comparisons A with B and A with C, corresponding to inter-human agreement 
compared to human with ML. Significant differences are marked with bold. For all patients there was no 
difference in inter-rater agreement compared with ML against rater 1 for DSC, HD, or ASD (A–B: p = 0.08, p 
= 0.60, and p = 0.05, respectively) whereas lower agreement was observed between rater 2 and ML compared 
to inter-rater agreement for DSC, HD, and ASD (A–C p ≤   0.0072 for all). Similar differences between ML 
and rater 2 compared to inter-rater agreement were found for the endometroid subtype (p ≤  0.01), but not 
for rater 1. No statistical differences in performance were detected for non-endometroid subtype although the 
difference in estimates |A–B| and |A–C| of DSC and ASD were higher for non-endometroid subtype than for 
endometroid subtype.
I. Median DSC, HD, and ASD II. Statistical comparison
Parameter Subtype A (R1 vs. R2) B (R1 vs. ML) C (R2 vs. ML) |A–B| (p) |A–C| (p)
DSC
All patients 0.89 0.84 0.77 0.05 (0.08) 0.12 (< 0.001)
Endometroid 0.89 0.86 0.81 0.03 (0.12) 0.08 (< 0.001)
Non-endometroid 0.90 0.52 0.48 0.38 (0.44) 0.41 (0.13)
HD (mm)
All patients 5.15 6.40 8.69 1.25 (0.60) 3.54 (0.0072)
Endometroid 5.10 5.83 7.07 0.73 (0.93) 1.97 (< 0.001)
Non-endometroid 3.46 9.43 10.0 5.97 (0.06) 6.54 (0.13)
ASD (mm)
All patients 0.42 1.08 1.43 0.66 (0.05) 1.00 (< 0.001)
Endometroid 0.43 0.98 1.06 0.55 (0.11) 0.63 (0.005)
Non-endometroid 0.40 6.10 6.09 5.70 (0.55) 5.68 (0.31)
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Pairwise comparisons in terms of DSC and HD revealed that inter-rater agreement was not different to 
agreement between rater 1 with ML, neither in terms of DSC, HD or ASD (Table 1, panel II, A–B, Wilcoxon 
signed rank test, p = 0.08, p = 0.60, and p = 0.05, respectively). However, inter-rater agreement was higher than 
agreement between rater 2 and ML in terms of DSC HD, and ASD (Table 1, panel II, A–C, Wilcoxon signed rank 
test, p < 0.001, p = 0.0072, and p < 0.001).
Segmentation performance for the endometroid subtype was similar to that of the full cohort, with a statistical 
difference in performance between inter-rater agreement and between rater 2 and ML, in terms of DSC, HD, and 
ASD (Table 1, panel II, Endometroid, A–C, Wilcoxon signed rank test, p<0.001, p<0.001, p = 0.005), whereas 
such a difference was not found for rater 1 and ML compared to inter-rater agreement. No statistical differences 
on segmentation performance was observed for non-endometroid subtype, although the differences in estimates 
A–B and A–C of DSC, HD and ASD were larger than for the endometroid subtype.
Discussion
This study presents a fully automatic approach for segmentation of primary tumor in endometrial cancer using 
three-dimensional convolutional neural networks applied to preoperative pelvic MR images. By this approach, 
tumor volume estimates and segmentation accuracy based on CNNs are comparable to manual segmentation 
by radiologists. Automated and precise tumor segmentation using CNN provides new opportunities for expedi-
tious whole-volume radiomic tumor profiling, potentially yielding prognostic markers that may enable more 
personalized EC treatment.
We found no difference in median tumor volume between human raters and machine learning (Friedman 
test, p = 0.28 ), suggesting that on average for a larger sample, the machine learning application has no detectable 
bias. Hence, the automatic segmentation method has potential to reveal systematic changes in tumor volume 
between groups in response to various treatment strategies, with a high value in clinical drug trials.
In regard to individual tumor volume estimates, we found a very high agreement in log tumor volume between 
human raters (ICCR1,R2 = 0.86). High agreement in machine learning log tumor volume and any of the raters was 
also observed (ICCR,ML = 0.76). Importantly, there was no significant difference in these ICC estimates, suggest-
ing that the network provides a comparable agreement with human experts as between humans.
We also investigated volumetric segmentation accuracy in terms of Dice similarity coefficients (DSC), average 
surface distance (ASD), and Hausdorff distances (HD).
Notably, the expert raters disagreed substantially on primary tumor placement in five out of 35 patients (cfr. 
Fig. 5, open dots in left panel). Interestingly, these five cases had similar tumor size to that of the non-outliers 
(Wilcoxon rank sum test, p = 0.43 ); thus, the observed disagreement is not due to smaller tumor size but seems 
to be due to less obvious factors causing lower agreement for tumor segmentations.
Human agreement compared to CNN showed no differences when network performance was compared to 
rater 1 in terms of DSC, HD and ASD (Table 1, Wilcoxon signed rank test, p = 0.08 , p = 0.60 , and p = 0.05 
respectively). The absolute difference in estimate compared to inter-rater agreement was DSC = 0.05, HD = 
1.25 mm, and ASD = 0.66 mm. However, when comparing CNN performance with rater 2, human agreement 
was better in terms of all evaluation criteria DSC, HD, and ASD (Wilcoxon signed rank test, p < 0.01) with a 
median difference in DSC = 0.12, HD = 3.54 mm, and ASD = 1.00 mm.
Similar results showing differences in performance between rater 2 and ML compared to inter-rater agreement 
were found in the endometroid subtype (Wilcoxon signed rank test, p < 0.005 , with absolute median differences 
in DSC = 0.08, HD = 1.97 mm, and ASD = 0.63 mm. No differences were found for rater 1. No significant dif-
ference in agreement was observed in the non-endometroid subtype although the differences in estimate were 
larger than in the endometroid group (maximum |A-B| and |A-C|: DSC = 0.41, HD = 6.54 mm, and ASD = 5.70 
mm). Notably, the results must be interpreted with care due to the low number of patients with non-endometroid 
subtype in the test cohort (n = 5).
The differences found between raters and ML probably reflects that the CNN was trained on more labeled 
training masks from rater 1 (n = 79) than from rater 2 (n = 26). However, our study indicates that even with 
the relatively small number of training masks provided by rater 1, it was possible to create a CNN yielding high 
agreement with rater 1, similar to the inter-rater agreement of human experts. Thus, we hypothesize that by 
including more labeled data sets from rater 2, it is likely that the segmentation network would be able to yield 
similar agreements between ML and both readers and at the same level as the inter-rater agreement. Thus, we 
believe that if adding multiple raters who all segment a substantial number of data sets, the network is likely to 
perform at a comparable level to that of all raters.
Furthermore, we found no differences in Hausdorff distances between inter-rater agreement and ML com-
pared with rater 1. This result points out that the CNN was able to provide tumor masks with predominantly 
locally extending variations around the tumor in comparison to human experts. This is a highly interesting find-
ing in this study, as it suggests that most over- and under-segmentation errors are localized close to the tumor 
periphery. Visual inspection of the segmented data sets also confirmed this hypothesis. As such, we have reason 
to believe that the central tumor areas are most reliably detected by the CNN approach, with a large potential 
for automatic generation of tumor texture variables that reportedly yield promising imaging biomarkers for 
classification into low- and high-risk disease.
An important limitation of our study is the relatively small cohort used for training of the CNNs. Hence, a 
follow-up study should be based on larger multi-center imaging data including heterogeneous data from different 
vendors, acquisitions, human operators, and patient groups. The study is also limited by the inherent limitations 
of retrospective as opposed to prospective designs. Accurate manual tumor labeling of 3D image data is highly 
labor intensive, and future studies on automated EC tumor segmentation should explore whether using novel 
methodologies for semi-22 and partially  supervised23 learning is able to yield even better segmentation accuracy.
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In brief, this study shows that existing machine learning algorithms are able to provide reliable tumor seg-
mentations at human expert level in endometrial cancer patients. Our setup yields tumor volume, tumor bounda-
ries, and volumetric tumor maps. Hence, the automatic approach for EC primary tumor segmentation has the 
potential to provide close to real-time whole-volume radiomic tumor profiling including tumor volume and 
tumor texture properties, with potential relevance for risk-stratification and for developing more personalized 
treatment strategies in endometrial cancer.
Methods
The current work is a retrospective study of a cohort of 139 endometrial cancer patients undergoing pelvic MR 
imaging prior to hysterectomy between May 2009 and April  20196. Eligible participants formed a random selec-
tion taken from a consecutive series of patients. The patients were diagnosed and treated at Haukeland University 
Hospital, serving a population of  1 million inhabitants from the Western part of Norway. Inclusion criterion 
was histologically confirmed endometrial cancer, and diagnostics was confirmed in a routine diagnostic work-
up. The study was conducted under approval of REC West, the Regional Committee for Medical and Health 
Research Ethics with written informed consent from all patients. All experiments and methods were performed 
in accordance with relevant guidelines and regulations. The patient cohort was previously used in the context of 
other research questions than segmentation, with a maximum overlap of n = 70  patients2,3,6,7.
Histologic subtype was endometrioid ( n = 114 ) or non-endometroid ( n = 25 ) (comprising clear cell, serous 
papillary, carcinosarcoma, or undifferentiated subtype). The number of patients with endometrioid and non-
endometrioid subtype in the train/validation and test cohorts were 85+ 29 (endometroid) and 20+ 5 (non-
endometroid), respectively. Segmentation performance was analyzed separately for the two histologic subtypes.
MRI protocol. Patients in the cohort underwent preoperative pelvic MRI examinations at Haukeland Uni-
versity Hospital, Bergen, Norway, either on a 1.5T Siemens Avanto MR scanner ( n = 71 ), or on a 3T Siemens 
Skyra MR scanner ( n = 68 ). The imaging sequence (Table 2) used in this study was a contrast enhanced (2 min 
delay after contrast injection ) T1-weighted axial oblique 3D volumetric interpolated breath-hold (VIBE) gradi-
ent echo sequence with fat saturation. DICOM image data were exported to NIfTI-1 data  format24 employing the 
DICOM to NIfTI conversion tool mri_convert.
Deep learning methodology. A 3D convolutional neural network (UNet3D)21 using  Keras25 (https ://
githu b.com/keras -team/keras .git) and  Tensorflow26 as backend engine was used for 3D segmentation of endo-
metrial primary tumors. The core network implementation was retrieved from github https ://githu b.com/ellis 
dg/3DUne tCNN21 and wrapped into a dedicated Python implementation facilitating data augmentation, train-
ing, validation, and prediction. A customized image data generator for 3D images was applied for data augmen-
tation (https ://githu b.com/keras -team/keras /blob/maste r/keras /prepr ocess ing/image .py), including rotation 
(rotation_range = 0.1), zooming (zoom_range = 0.15), and horizontal flip. For each patient, eight randomly 
placed window samples were extracted for training. Windows sampled with overlap to the image boundary 
or background levels were not allowed in order to avoid padding out-of-view data for training. A majority of 
default parameter settings were applied for training of the CNN. Default parameters are marked with *: Shape of 
input data = (192, 192, 32) voxels3 , depth of the U-shape of the model = 4, initial learning rate* = 1e−5 (learn-
ing rate was decayed during training), poolsize for max pooling operations* = (2,2,2), number of base filters in 
the first layer in the convolution network* = 32, convolution (deconvolution) operations instead of upsampling* 
= False, maximum number of epochs = 1500, activation function = “sigmoid” , batch normalization* = False, 
number of labels = 1, metrics* = Dice coefficient, batch size = 5, and optimizer = RMSprop. The training data set 
was randomly shuffled between epochs.
Exploration and tuning of hyperparameters included modifying the shape of input data, depth of the model, 
number of base filters, convolution (deconvolution) operations/upsampling, activation function = sigmoid/
ReLu, and batch normalization False/True. A train/validation split of 0.2 was applied to the input data of the 
model. Convergence of the model was monitored on the validation data set with patience = 30 from keras.
callbacks.EarlyStopping in order to stop training when there is no further improvement of the model. 
The machine-learning (ML) network resulted in smooth predictions. A higher prediction value is associated with 
a higher likelihood of tumor tissue, and a lower value is conversely associated with non-malignant tissue. The 
human raters were primed to outline the primary tumor only. In order to setup the machine learning similarly, 
Table 2.  MR acquisitions used in the project for segmentation of primary tumors in endometrial cancer. 
deg = degrees, mm = millimeter, ms=millisecond, FA = flip angle, FOV = field of view, PA = paraxial slice 
orientation, TE = echo time, TR = repetition time, VIBE = Volumetric Interpolated Breath-hold Examination, 
FS = fat saturated.
MR machine Sequence Plane TR/TE (ms) FA (deg)
Slice thickness 
(mm) Matrix FOV (mm3) Voxel size (mm3)
1.5T Siemens Avanto 
( n = 71) FS T1 VIBE PA 7.23/2.55 17 2.0 192× 192 250× 250× 96 1.30× 1.30× 2.00
3T Siemens Skyra 
( n = 68) T1 VIBE DIXON PA 5.86/2.46 9 1.2 160× 160 227× 250× 106 0.98× 0.98× 1.20
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we labelled all disconnected objects in space provided by the ML upon prediction of new patients, only preserv-
ing the largest object.
Assignment of training and validation data. 3D masks of the primary tumor aligned with the VIBE 
imaging data were outlined by two expert radiologists (rater 1 = J.A.D. with> 4 years of experience with pelvic 
imaging; rater 2 = K.S.W-L. with > 10 years of experience with pelvic imaging). Tissue associated with primary 
tumor was assigned a value of one, while remaining tissue was designated the value zero. The radiologists were 
blinded to each other’s segmentations. A total of n = 34 patients was outlined by both raters and is referred to as 
the test data set. The test data set was unseen by the training algorithm and used for an unbiased evaluation of 
segmentation performance after training was completed. A total number of 105 patients were outlined by either 
one of the radiologists (nrater1 = 79, n rater2 = 26). This data set was randomly split into a train (n = 84 patients) and 
a validation data set (n = 21), (in agreement with a train/validation split of 0.2). The validation data set was used 
to obtain an unbiased evaluation of the model fit on the training data set while tuning model hyperparameters. 
Each rater tumor volumes are referred to as VR1 and VR2 , while machine learning tumor volume is referred to as 
VML . The radiologists had access to VIBE, T2-weighted images, and DWI (diffusion weighted imaging) b1000 
images when performing manual tumor delineation in order to imitate routine radiological work-up.
Metrices for evaluation of segmentation performance. Segmentation performance was estimated 
for the test data set. We evaluated volumetric segmentation accuracy according to the Dice similarity coefficient 
(DSC), limiting to 0 ≤ DSC ≤  127. A high value of DSC indicates high performance of the segmentation. The Dice 
similarity coefficient is a volumetric measure for segmentation performance, which to a limited extent is sensi-
tive to outliers. For this reason, we also computed the Hausdorff distance, defined as the greatest of all distances 
from a point in one set to the closest point in the other set. Hausdorff distances (HD) were computed using the 
python library function directed_hausdorff implemented in scipy. A low Hausdorff distance indicates 
high segmentation accuracy in terms of boundary similarity.
In order to map segmentation errors in the outer tumor boundaries, we also computed average surface dis-
tance (ASD) measured from the ground truth mask surface to the ML mask surface in the Euclidean  sense28. A 
smaller value of ASD is associated with an improved segmentation.
Statistical analyses were performed in MATLAB with Statistics Toolbox Release 2018b and using R (https ://
www.r-proje ct.org) for statistical computing. Statistical hypothesis testing was performed under a significance 
level of α=0.05. Lilliefors goodness-of-fit test of composite normality (Lillietest in MATLAB) was used to 
determine whether sample data was drawn from a normally distributed population. Whenever non-normality 
data distribution, a non-parametric statistical test was applied. Assessment of consistency in log tumor volume 
estimates was performed with the intraclass correlation coefficient (ICC). Bland-Altman plots are shown to visu-
alize agreement in tumor volumes. Limits of agreement (LoA) are calculated as the mean difference +/− 1.96 
standard deviation of the difference. Box plots are used to visualize sample tumor volumes, Dice similarity coef-
ficients and Hausdorff distances. Friedman test for multiple comparison was used to assess rank differences in 
tumor volume estimates between the raters and ML.
Differences in DSC, HD, and ASD between humans and machine were explored along Wilcoxon signed rank 
test. We computed a set of three agreements A, B, and C where A = rater 1 against rater 2, B = rater 1 against 
ML, and C = rater 2 against ML (cfr. Table 1). Individual differences in the three agreements were accessed by 
pairwise subtraction and testing for zero median applied to A-B and A-C.
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